Agios Pharmaceuticals AGIO Income Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $54.03M+48.0% | $36.5M+36.1% | $26.82M+88.4% | $14.24M— | ||
| $6.35M+52.3% | $4.17M+44.6% | $2.88M+69.1% | $1.7M— | ||
| $47.68M+47.5% | $32.33M+35.0% | $23.94M+91.0% | $12.54M— | ||
| 88.3%-0.3pp | 88.6%-0.7pp | 89.3%+1.2pp | 88%— | ||
| $339.54M+12.7% | $301.29M+1.9% | $295.53M+5.6% | $279.91M+8.9% | ||
| $180.28M+15.0% | $156.78M+30.8% | $119.9M-1.5% | $121.67M+0.2% | ||
| $526.16M+13.8% | $462.24M+10.5% | $418.31M+3.7% | $403.29M+6.6% | ||
| -$472.13M-10.9% | -$425.74M-8.7% | -$391.49M-0.6% | -$389.05M-2.8% | ||
| -873.9%+293pp | -1,166.5%+293pp | -1,459.5%+1,273pp | -2,732.1%— | ||
| $56.38M+17.3% | $48.08M+44.2% | $33.34M— | —— | ||
| $1.96M-69.8% | $6.49M+7.1% | $6.06M-10.3% | $6.75M-53.2% | ||
| -$412.78M— | —— | -$352.09M— | —— | ||
| -764%— | —— | -1,312.6%— | —— | ||
| -$7.11— | —— | -$6.34— | —— | ||
| -$7.11— | —— | -$6.34— | —— | ||
| 231.5M+0.9% | 229.5M+3.2% | 222.3M+1.5% | 219M-11.7% | ||
| 231.5M+2.0% | 226.9M+2.1% | 222.3M+1.5% | 219M-11.7% | ||
| $56.38M+17.3% | $48.08M+44.2% | $33.34M— | —— | ||
| $1.96M-69.8% | $6.49M+7.1% | $6.06M-10.3% | $6.75M-53.2% | ||
| $54.03M+48.0% | $36.5M+36.1% | $26.82M+88.4% | $14.24M— | ||
| -$472.13M-10.9% | -$425.74M-8.7% | -$391.49M-0.6% | -$389.05M-2.8% | ||
| -$466.96M-11.2% | -$420.08M-9.2% | -$384.86M-1.2% | -$380.48M-3.1% | ||
| -$466.96M-11.2% | -$420.08M-9.2% | -$384.86M-1.2% | -$380.48M-3.1% | ||
| -864.3%+287pp | -1,151%+284pp | -1,434.8%+1,237pp | -2,671.9%— | ||
| -$472.13M-10.9% | -$425.74M-8.7% | -$391.49M-0.6% | -$389.05M-2.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Agios Pharmaceuticals's profit margins?
- Gross margin is 90.0% and operating margin is -720.0%, with a -639.8% net margin.
- Where does Agios Pharmaceuticals's income statement data come from?
- Every line is extracted from Agios Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.